CAS 10101-89-0 - China Manufacturers, Suppliers, Factory

CAS 10101-89-0, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)
Read More

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

DL-2,3-Diaminopropionic Acid Hydrochloride CAS 54897-59-5 Assay 98.5-101.5% (Titration) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...
Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.12.13 18:32:48
2022.08.22 04:31:38
2022.07.25 20:43:20
2022.05.04 08:24:50
2022.04.11 14:11:31
2022.02.28 13:26:35

CAS 10101-89-0 - China Manufacturers, Suppliers, Factory

Related Products

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

DL-2,3-Diaminopropionic Acid Hydrochloride CAS 54897-59-5 Assay 98.5-101.5% (Titration) Purity ≥99.0% (HPLC)

Top Selling Products

D-Phenylalanine CAS 673-06-3 (H-D-Phe-OH) Assay 98.0~102.0% Factory 50MT/Month

Boc-L-Tryptophanol CAS 82689-19-8 Boc-Trp-Ol Purity >98.0% (HPLC)

2-Bromo-3-Nitropyridine CAS 19755-53-4 Purity >99.0% (GC) Factory

Fmoc-Lys(Tfa)-OH CAS 76265-69-5 Purity >98.5% (HPLC)

4-(Methoxycarbonyl)phenylboronic Acid CAS 99768-12-4 Purity >99.5% (HPLC) Factory High Quality

H-D-Val-OtBu·HCl CAS 104944-18-5 D-Valine tert-Butyl Ester Hydrochloride Assay ≥98.0% (HPLC)

1-Cbz-4-Piperidone CAS 19099-93-5 Purity >98.5% (GC)

6,7-Bis(2-Methoxyethoxy)-4(3H)-Quinazolinone CAS 179688-29-0 Erlotinib Hydrochloride Intermediate Purity >99.0% (HPLC)

2-Amino-5-Bromopyrazine CAS 59489-71-3 Purity >99.0% (HPLC) Factory High Quality

Perfluorobutanesulfonyl Fluoride CAS 375-72-4 Purity >97.0% (GC)

2-Aminoimidazole Hemisulfate CAS 1450-93-7 Purity ≥98.5% (HPLC) Factory High Quality

Fmoc-Lys(Alloc)-OH CAS 146982-27-6 Purity >98.5% (HPLC) Factory

The “Summit on COVID-19 Diagnostics & Treatment”

Xi presents award to top scientists

Yellow phosphorus and phosphoric acid rose together

Method Of Analyzing Palladium Content In Palladium Catalysts

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

2022.12.13 18:32:48

2022.08.22 04:31:38

2022.07.25 20:43:20

2022.05.04 08:24:50

2022.04.11 14:11:31

2022.02.28 13:26:35

related search